Product Information

DOXEPIN 100 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.3144 per EA under NDC 62332064031. Its NADAC has been published 267 times since Oct 13, 2021.

FDA first approved this application on Apr 21, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOXEPIN 100 MG CAPSULE

DOXEPIN HYDROCHLORIDE
$0.3144per EA

Strength

100 mg/1

NDC

62332064031

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DOXEPIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215076

FDA Approved

4/21/2021

TE Code

AB

On Market Since

4/23/2021

Pharmacological Classes

Price Statistics

The NADAC for DOXEPIN 100 MG CAPSULE has been published 267 times since Oct 13, 2021, and over the history we have for it it has declined 39.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3144 per EA
All-time high$0.6888 (Jul 13, 2022)
All-time low$0.2255 (Feb 19, 2025)
52-week high$0.3144
52-week low$0.2459
Median price$0.3165
Average price$0.3673
Largest weekly change+46.8% (Aug 21, 2024)
Weeks tracked267
Tracking sinceOct 13, 2021

Price History

1W

+4.2%

1M

+8.4%

3M

+17.8%

6M

+18.9%

1Y

+22.1%

3Y

-3.6%

5Y

-54.0%

All

-39.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 5%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DOXEPIN 100 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 100 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $0.3144 per EA (NDC 62332064031), effective Nov 18, 2026.

How has the price of DOXEPIN 100 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DOXEPIN 100 MG CAPSULE has declined 39.3%. It has been tracked across 267 weekly CMS publications since Oct 13, 2021.

What are the highest and lowest recorded NADAC prices for DOXEPIN 100 MG CAPSULE?

Since Oct 13, 2021, the NADAC for DOXEPIN 100 MG CAPSULE has ranged from a low of $0.2255 (Feb 19, 2025) to a high of $0.6888 (Jul 13, 2022), with a median of $0.3165 per EA.

Are there cheaper alternatives to DOXEPIN 100 MG CAPSULE?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXEPIN 100 MG CAPSULE, is $0.2992 per EA — about 5% below DOXEPIN 100 MG CAPSULE.

Who manufactures DOXEPIN 100 MG CAPSULE?

DOXEPIN 100 MG CAPSULE (NDC 62332064031) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.